A study led by researchers at Baylor College of Medicine has uncovered a new strategy that can potentially treat age-related disease and decline.
The study, published in the journal Cell Metabolism, demonstrates that shortening of telomeres – the ends of the chromosomes – impairs a class of enzymes called sirtuins, which play an important role in maintaining cell fitness by affecting many metabolic processes and repairing damaged chromosomes. The researchers showed that restoring the activity of sirtuins with a small compound stabilized telomeres and reduced DNA damage, which in turn improved liver disease in a mouse model. These studies suggest that maintaining telomere length might help sustain the regenerative capacity of cells and tissues and improve disease outcome.
“Our genetic material is tightly packed into thread-like structures called chromosomes and at the ends of the chromosomes are particular pieces of DNA called telomeres. Telomeres work like the plastic tips at the end of shoelaces; they prevent chromosomes from unraveling or sticking to each other,” said Dr. Ergun Sahin, lead investigator and assistant professor in the Huffington Center on Aging and the Department of Molecular Physiology and Biophysics at Baylor.
Telomeres also are involved in aging and disease; as an organism gets older, telomeres shorten and cells progressively deteriorate, stop dividing and die. Telomere shortening during human aging is believed to be a major underlying cause of age-related decline of stem cells – cells with the potential to develop into many different types of cells and help in the healing process in the body. Telomere shortening also affects the susceptibility of tissues to disease; however, how telomere shortening impairs regeneration and increases risk of disease is not well understood. Evidence suggests that stabilizing telomeres could prevent or slow down aging and disease. In this study, Sahin and his colleagues investigated the effect of restoring telomere length in a mouse model of liver tissue fibrosis
Telomere shortening has been associated with increased risk of organ failure and tissue fibrosis, usually in liver and lung, as cells with compromised telomeres fail to divide to replace dying cells.
Previous studies have shown that both telomeres and sirtuins contribute to aging and tissue fibrosis and seemed to interact with each other. In this study, Sahin and his colleagues investigated the molecular mechanisms that connected telomeres and sirtuins. For this, they developed a mouse model of liver disease in which the animals were genetically engineered to develop shorter, dysfunctional telomeres and age prematurely. When exposed to certain compounds, these animals quickly develop liver fibrosis – scarring of the liver that over time can lead to cirrhosis.
“In these mice, we discovered that shorter telomeres triggered a reduction in the production of sirtuins in liver and other tissues as well,” Sahin said. “Telomere shortening signaled the cell to reduce the production of sirtuins. This observation indicates that telomeres regulate sirtuins.”
Interestingly, the researchers also found that in turn, sirtuins can affect telomeres. When Sahin and his colleagues increased the activity of sirtuins by feeding mice a small molecule – nicotinamide mono mononucleotide, or NMN, an NAD+ precursor – telomeres were stabilized.
“Furthermore, feeding NAD+ precursor to the mice not only maintained telomere length but also improved liver condition in these mice,” Sahin said.
More research is needed before these findings can be translated into treatments for human conditions.
“It’s important to keep in mind that telomere length can also affect cancer growth. Having shorter telomeres would set cancer cells on a path to self-destruction, but keeping their telomeres long would likely allow them to continue proliferating,” Sahin said. “We plan to continue our investigation on the molecular mechanisms involved in the telomere-sirtuin interactions in order to better understand the benefits as well as the potential risks of telomere length manipulation in health and disease.”
The Latest on: Age-related disease
via Google News
The Latest on: Age-related disease
- Tissue stiffness likely drives immune responses in many chronic diseaseson January 12, 2021 at 8:04 am
Stiffness in our tissues causes tension in our cells. Research shows that stiffness impacts the innate immune system by upping its metabolism. Buck Institute findings suggest the cellular tension ...
- Turn Biotechnologies Licenses Revolutionary Technology to Unwind the Effects of Aging at a Cellular Levelon January 12, 2021 at 5:51 am
Turn Biotechnologies, a company developing medicines for currently untreatable age-related conditions, announced that it has acquired ...
- Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Deviceon January 12, 2021 at 5:35 am
Notal Vision, Inc. announced today that the company initiated the first US-based study using its investigational home-based optical coherence tomography (OCT) platform. The study will evaluate the ...
- CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs ...on January 12, 2021 at 1:44 am
The NIAID will be responsible for any study conducted under the NCEA. Under the agreement, NIAID will be provided with CohBar’s CB5064 Analogs to test in preclinical models of COVID-19, such as the ...
- 8 Tips for Vision Health During the Pandemicon January 11, 2021 at 3:20 pm
Many are forgoing their regular vision health appointments because of the pandemic. Here are some things you can do at home to preserve eye health.
- Wet Age Related Macular Degeneration (AMD) Market : Facts, Figures and Analytical Insights 2021-2027on January 11, 2021 at 2:43 pm
The Wet Age Related Macular Degeneration (AMD) Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and ...
- EyePoint Pharmaceuticals Provides Business Update and Preliminary Fourth Quarter and Full-Year 2020 Net Product Revenueson January 11, 2021 at 1:23 pm
IND filed in December 2020 for EYP-1901, a potential six-month sustained delivery intravitreal anti-VEGF treatment targeting wet age-related ...
- CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs for Treatment of COVID-19 ARDSon January 11, 2021 at 6:00 am
CohBar, Inc., a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced it has signed a Non-Clinical ...
- Women In Longevity Medicine: Dr. Dina Radenkovicon January 11, 2021 at 4:29 am
The longevity medicine industry is rapidly evolving and we are witnessing the advent of a new profession - longevity physician. Incorporating deep aging clocks in her diagnostic and therapeutic ...
- Alzheimers Q&A: What are the warning signs of Alzheimer's disease?on January 11, 2021 at 4:00 am
Alzheimer’s disease is a degenerative brain disorder that has no cure. There's no way to slow or stop its progression, and there's no proven way to prevent it.
via Bing News